StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) PT Raised to $11 at Cowen
August 5, 2020 1:04 PM
Cowen analyst Ken Cacciatore raised the price target on Teva Pharma (NYSE: TEVA) to $11.00 (from $9.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Teva Pharm second-quarter profit tops forecast, reaffirms 2020 outlook
August 5, 2020 7:21 AM
Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
August 5, 2020 7:10 AM
Teva Pharma (TEVA) Tops Q2 EPS by 2c, Affirms Outlook
August 5, 2020 7:02 AM